Vascular stiffening and arterial compliance. Implications for systolic blood pressure
- PMID: 15607434
- DOI: 10.1016/j.amjhyper.2004.08.019
Vascular stiffening and arterial compliance. Implications for systolic blood pressure
Abstract
Hypertension in older persons is characterized by increased systolic blood pressure, and isolated systolic hypertension (ISH) is the most common type of hypertension in this population. It is thought that ISH results from age-associated vascular stiffening and reduced compliance that can be revealed and quantified by analysis of arterial pressure waveforms. Evaluation of pulse wave velocity and other related measures has shown that arterial stiffness increases with advancing age and other cardiovascular (CV) risk factors including hypertension, the metabolic syndrome, diabetes, obesity, hypercholesterolemia, and elevated C-reactive protein. Many of these relationships have been demonstrated in patients without clinical CV disease and are independent of patient age. Arterial stiffness is significantly and independently associated with both target organ damage and increased risk for CV morbidity and mortality. The mechanisms underlying age- and disease-related arterial stiffening are not fully understood. However, assessment of changes in gene expression associated with increased arterial stiffness and gene polymorphisms that increase the risk for vascular stiffening suggests that components of the renin-angiotensin system, matrix metalloproteinases, intracellular signaling, and extracellular matrix components may all be involved in this process. Interventions aimed at these targets may reduce vascular stiffness, lower systolic blood pressure, decrease the prevalence of ISH, and improve outcomes for patients (particularly older patients) with hypertension or other CV conditions.
Similar articles
-
Large-artery stiffness, hypertension and cardiovascular risk in older patients.Nat Clin Pract Cardiovasc Med. 2005 Sep;2(9):450-5. doi: 10.1038/ncpcardio0307. Nat Clin Pract Cardiovasc Med. 2005. PMID: 16265585 Review.
-
Matrix metalloproteinase-9 (MMP-9), MMP-2, and serum elastase activity are associated with systolic hypertension and arterial stiffness.Arterioscler Thromb Vasc Biol. 2005 Feb;25(2):372. doi: 10.1161/01.ATV.0000151373.33830.41. Epub 2004 Nov 18. Arterioscler Thromb Vasc Biol. 2005. PMID: 15556929
-
Clinical measurement of arterial stiffness obtained from noninvasive pressure waveforms.Am J Hypertens. 2005 Jan;18(1 Pt 2):3S-10S. doi: 10.1016/j.amjhyper.2004.10.009. Am J Hypertens. 2005. PMID: 15683725 Review.
-
[Arterial compliance (stiffness) as a marker of subclinical atherosclerosis].Herz. 2007 Aug;32(5):379-86. doi: 10.1007/s00059-007-3030-z. Herz. 2007. PMID: 17687527 Review. German.
-
Systolic blood pressure: it's time to take control.Am J Hypertens. 2004 Dec;17(12 Pt 2):49S-54S. doi: 10.1016/j.amjhyper.2004.08.020. Am J Hypertens. 2004. PMID: 15607435 Review.
Cited by
-
Changes in aortic pulse wave velocity in hypertensive postmenopausal women: comparison between a calcium channel blocker vs angiotensin receptor blocker regimen.J Clin Hypertens (Greenwich). 2012 Nov;14(11):773-8. doi: 10.1111/jch.12004. Epub 2012 Sep 12. J Clin Hypertens (Greenwich). 2012. PMID: 23126349 Free PMC article. Clinical Trial.
-
Targeting the vasculature in cardiometabolic disease.J Clin Invest. 2022 Mar 15;132(6):e148556. doi: 10.1172/JCI148556. J Clin Invest. 2022. PMID: 35289308 Free PMC article. Review.
-
Volume of the proximal half of the thoracic aorta is the most comprehensive FDG-PET/CT indicator of arterial aging throughout adulthood.Eur J Hybrid Imaging. 2023 Jun 28;7(1):11. doi: 10.1186/s41824-023-00169-2. Eur J Hybrid Imaging. 2023. PMID: 37369917 Free PMC article.
-
Role of the vascular endothelial sodium channel activation in the genesis of pathologically increased cardiovascular stiffness.Cardiovasc Res. 2022 Jan 7;118(1):130-140. doi: 10.1093/cvr/cvaa326. Cardiovasc Res. 2022. PMID: 33188592 Free PMC article. Review.
-
Increased inflammation, reduced plasma phospholipid eicosapentaenoic acid and reduced antioxidant potential of treated hypertensive patients with metabolic syndrome.Yonsei Med J. 2009 Dec 31;50(6):757-63. doi: 10.3349/ymj.2009.50.6.757. Epub 2009 Dec 18. Yonsei Med J. 2009. PMID: 20046414 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials